Brigit Biofarmaka Teknologi Tbk. vs Repower Asia Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume), while Repower Asia Indonesia Tbk. trades at Rp53 (market cap 351.58B, 40.49M 24h volume). The key difference: Repower Asia Indonesia Tbk. is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Repower Asia Indonesia Tbk. is more actively traded (40.49M versus 187.4K). Which is the better fit depends on your goals.
| OBAT | REAL | |
|---|---|---|
Market Cap | 164.65B | 351.58B |
Volume | 187.4K | 40.49M |
Lot | 1.87K | 404.91K |
Turnover | 44.35M | 2.13B |
Average Price | 236.67 | 52.49 |
Value | 44.35M | 2.13B |
Indicative Equilibrium Price | 242 | 53 |
Indicative Equilibrium Volume | 500 | 18.42K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Repower Asia Indonesia Tbk (the Company) was established based on Notarial Deed No. 04 of Titik Krisna Murti Wikaningsih, S.H., M.KN., dated March 13, 2011, a Notary in Bekasi.
Read more on REAL →